NAPE-PLD Blocking Peptide (aa 6-20)
NAPE-PLD Blocking Peptide (aa 6-20)
To be used in conjunction with Cayman’s NAPE-PLD polyclonal antibody (aa 6-20) (Item No. 10306) to block protein-antibody complex formation...
€199.00
ViewPrice:
€182.00
€182.00
The affinity sorbent A19482 is produced by our labs; it is an immobilized mouse monoclonal antibody anti-CGRP on a matrix resin. The vial contains 1mL of sorbent which can treat up to 20mL sample volume. The use of sorbent will provide you with CGRP-free plasma/serum (pool 4 to 5 plasmas/serums together in order to decrease the variability between animals), and then reconstitute the CGRP standards and QC with free-CGRP serum.
Territorial Availability: Available worldwide directly through Bertin or your local distributor
| Size | 1 ea |
|---|---|
| Shipping | wet ice |
| Application(s) | Add up to 20 mL of plasma or biological sample., Let it incubate overnight at +4°C with gentle agitation., let the plasma or biological sample elute entirely (the gel should become dry but not for a long time)., Pour the mixture in an empty column (around 10 x 1 cm) with a filter at the end., Put 1 mL of sorbent in a tube., ready to be used to dilute standards, Remove the bottom cap, samples in the assay., The eluted plasma or biological sample is now free of CGRP, The following is the purification protocol to generate CGRP-free biological samples |
| Custom code | 3822000000 |
| UNSPSC code | 12352200 |
To be used in conjunction with Cayman’s NAPE-PLD polyclonal antibody (aa 6-20) (Item No. 10306) to block protein-antibody complex formation...
Proprotein convertase subtilisin kexin 9 (PCSK9) is a member of the subtilisin serine protease family with an important role in...
This mixture contains primary prostaglandins produced from arachidonic acid and dihomo-?-linolenic acid. Contents: Prostaglandin E1, Prostaglandin E2, Prostaglandin F1?, 6-keto...
Headquarters:
Parc d’activités du Pas du Lac
10 bis avenue Ampère
78180 Montigny le Bretonneux
France
Copyright © 2024 BERTIN BIOREAGENT. All rights reserved | Terms & conditions
